1. Home
  2. JBI vs ATXS Comparison

JBI vs ATXS Comparison

Compare JBI & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Janus International Group Inc.

JBI

Janus International Group Inc.

HOLD

Current Price

$6.43

Market Cap

821.8M

Sector

Industrials

ML Signal

HOLD

Logo Astria Therapeutics Inc.

ATXS

Astria Therapeutics Inc.

HOLD

Current Price

$12.96

Market Cap

722.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JBI
ATXS
Founded
2002
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
821.8M
722.1M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
JBI
ATXS
Price
$6.43
$12.96
Analyst Decision
Buy
Hold
Analyst Count
4
6
Target Price
$10.13
$24.33
AVG Volume (30 Days)
1.9M
992.4K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.34
N/A
Revenue
$888,700,000.00
$706,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.58
N/A
P/E Ratio
$18.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.73
$3.56
52 Week High
$10.80
$12.72

Technical Indicators

Market Signals
Indicator
JBI
ATXS
Relative Strength Index (RSI) 35.76 71.88
Support Level $5.97 $12.55
Resistance Level $6.28 $12.69
Average True Range (ATR) 0.24 0.20
MACD 0.14 -0.08
Stochastic Oscillator 97.14 99.26

Price Performance

Historical Comparison
JBI
ATXS

About JBI Janus International Group Inc.

Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. The company provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. The Janus International segment is comprised of a subsidiary whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities.

About ATXS Astria Therapeutics Inc.

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.

Share on Social Networks: